Cargando…
Immunosuppressants/Lopinavir/ritonavir: Elevated drug level, Covid 19 and reactivation of Herpes Zoster: 2 case reports
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7530873/ http://dx.doi.org/10.1007/s40278-020-84129-5 |
Ejemplares similares
-
Immunosuppressants/lopinavir/ritonavir interaction: Various toxicities: case report
Publicado: (2020) -
Baricitinib/lopinavir/ritonavir: Elevated transaminases and off-label use: case report
Publicado: (2020) -
Propofol/lopinavir/ritonavir: Bradyarrythmia: case report
Publicado: (2020) -
Immunosuppressants/lopinavir/ritonavir interaction: Relapse or persisting shedding of COVID-2019 , increased level of tacrolimus and off-label use: case report
Publicado: (2021) -
Crushing lopinavir/ritonavir tablets does not result in lower exposure to lopinavir/ritonavir in adult patients with COVID-19
por: Mohsenian Naghani, Shaghayegh, et al.
Publicado: (2023)